Developmental delay (disorder)
|
0.010 |
GeneticVariation
|
phenotype |
BEFREE |
Dystroglycanopathy with two novel POMT1 mutations in a Chinese boy with developmental delay and muscular dystrophy.
|
24657014 |
2014 |
Brain Diseases
|
0.010 |
AlteredExpression
|
group |
BEFREE |
We hypothesized a compromised integrity of the glia limitans-basal lamina complex due to glycosylation defects by loss of protein-o-mannosyltransferase-1 (POMT1) activity, also a well-known feature in developmental brain disorders with leptomeningeal heterotopia.
|
18647264 |
2009 |
Brain Neoplasms
|
0.010 |
GeneticVariation
|
group |
BEFREE |
Hypothesizing it as analogous in gliomas, we have performed a comprehensive polymerase chain reaction-single strand conformation polymorphism (PCR-SSCP) analysis of the POMT1 gene in 41 brain tumor specimens.
|
18647264 |
2009 |
Cleft palate with cleft lip
|
0.010 |
Biomarker
|
disease |
BEFREE |
We recommend POMT1 analysis in WWS cases associated with cleft lip and palate when considering which gene to sequence first.
|
18640039 |
2008 |
Cortical Dysplasia
|
0.010 |
Biomarker
|
disease |
BEFREE |
A MEB phenotype with frontal cortical dysplasia and pons abnormalities was found in two patients with POMT1 and in one with POMT2 mutations, while a WWS phenotype was only found in a case with mutations in POMT1.
|
18513969 |
2008 |
Limb-girdle muscular dystrophy type 2A
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
An autosomal recessive limb girdle muscular dystrophy (LGMD2) with mild mental retardation is allelic to Walker-Warburg syndrome (WWS) caused by a mutation in the POMT1 gene.
|
15792865 |
2005 |
Malformations of Cortical Development, Group II
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Mutations in the O-mannosyltransferase gene POMT1 give rise to the severe neuronal migration disorder Walker-Warburg syndrome.
|
12369018 |
2002 |
Neuromuscular Diseases
|
0.020 |
Biomarker
|
group |
BEFREE |
Just Expect It: Compound Heterozygous Variants of POMT1 in a Consanguineous Family-The Role of Next Generation Sequencing in Neuromuscular Disorders.
|
31627234 |
2020 |
Congenital Abnormality
|
0.020 |
GeneticVariation
|
group |
BEFREE |
Within this group mutations in the protein O-mannosyltransferase genes (POMT1 and POMT2) are known to cause a spectrum of CMD disorders including the Walker-Warburg Syndrome with severe brain and ocular malformations, and the limb girdle muscular dystrophy with and without mental retardation.
|
24556424 |
2014 |
Neuromuscular Diseases
|
0.020 |
GeneticVariation
|
group |
BEFREE |
Dystroglycan is a protein which binds directly to two proteins defective in muscular dystrophies (dystrophin and laminin alpha2) and whose own aberrant post-translational modification is the common aetiological route of neuromuscular diseases associated with mutations in genes encoding at least six other proteins (POMT1, POMT2, POMGnT1, LARGE, FKTN and FKRP).
|
20234391 |
2010 |
Congenital Abnormality
|
0.020 |
GeneticVariation
|
group |
BEFREE |
Mutations in POMT1 and POMT2 genes were originally identified in Walker-Warburg syndrome (WWS) and subsequently reported in patients with milder phenotypes characterised by mental retardation with or without brain abnormalities and without ocular malformations.
|
18513969 |
2008 |
Eye Abnormalities
|
0.020 |
GeneticVariation
|
group |
BEFREE |
Our data suggest the existence of a disease spectrum of CMD including brain and eye abnormalities resulting from POMT1 mutations.
|
16575835 |
2006 |
Eye Abnormalities
|
0.020 |
GeneticVariation
|
group |
BEFREE |
Mutations of the protein O-mannosyltransferase (POMT1) gene affect glycosylation of alpha-dystroglycan, leading to Walker-Warburg syndrome, a lethal disorder in early life with severe congenital muscular dystrophy, and brain and eye malformations.
|
15792865 |
2005 |
CRANIOMETAPHYSEAL DYSPLASIA, AUTOSOMAL DOMINANT
|
0.040 |
Biomarker
|
disease |
BEFREE |
Within this group mutations in the protein O-mannosyltransferase genes (POMT1 and POMT2) are known to cause a spectrum of CMD disorders including the Walker-Warburg Syndrome with severe brain and ocular malformations, and the limb girdle muscular dystrophy with and without mental retardation.
|
24556424 |
2014 |
CAMPOMELIC DYSPLASIA
|
0.040 |
Biomarker
|
disease |
BEFREE |
Within this group mutations in the protein O-mannosyltransferase genes (POMT1 and POMT2) are known to cause a spectrum of CMD disorders including the Walker-Warburg Syndrome with severe brain and ocular malformations, and the limb girdle muscular dystrophy with and without mental retardation.
|
24556424 |
2014 |
Coronary Microvascular Disease
|
0.040 |
Biomarker
|
disease |
BEFREE |
Within this group mutations in the protein O-mannosyltransferase genes (POMT1 and POMT2) are known to cause a spectrum of CMD disorders including the Walker-Warburg Syndrome with severe brain and ocular malformations, and the limb girdle muscular dystrophy with and without mental retardation.
|
24556424 |
2014 |
CRANIOMETAPHYSEAL DYSPLASIA, AUTOSOMAL DOMINANT
|
0.040 |
GeneticVariation
|
disease |
BEFREE |
We report three patients who harbored compound heterozygous POMT1 mutations and showed left ventricular (LV) dilation and/or decrease in myocardial contractile force: two had a LGMD phenotype with a normal or close-to-normal cognitive profile and one had CMD with mental retardation and normal brain MRI.
|
22549409 |
2012 |
CAMPOMELIC DYSPLASIA
|
0.040 |
GeneticVariation
|
disease |
BEFREE |
We report three patients who harbored compound heterozygous POMT1 mutations and showed left ventricular (LV) dilation and/or decrease in myocardial contractile force: two had a LGMD phenotype with a normal or close-to-normal cognitive profile and one had CMD with mental retardation and normal brain MRI.
|
22549409 |
2012 |
Coronary Microvascular Disease
|
0.040 |
GeneticVariation
|
disease |
BEFREE |
We report three patients who harbored compound heterozygous POMT1 mutations and showed left ventricular (LV) dilation and/or decrease in myocardial contractile force: two had a LGMD phenotype with a normal or close-to-normal cognitive profile and one had CMD with mental retardation and normal brain MRI.
|
22549409 |
2012 |
CRANIOMETAPHYSEAL DYSPLASIA, AUTOSOMAL DOMINANT
|
0.040 |
Biomarker
|
disease |
BEFREE |
As part of a multicentric Italian study we screened the POMT1 and POMT2 genes in 61 congenital muscular dystrophy (CMD) patients with alpha-dystroglycan reduction on muscle biopsy and/or clinical and radiological findings suggestive of the known forms of CMD with alpha-dystroglycan deficiency.
|
18513969 |
2008 |
CAMPOMELIC DYSPLASIA
|
0.040 |
Biomarker
|
disease |
BEFREE |
As part of a multicentric Italian study we screened the POMT1 and POMT2 genes in 61 congenital muscular dystrophy (CMD) patients with alpha-dystroglycan reduction on muscle biopsy and/or clinical and radiological findings suggestive of the known forms of CMD with alpha-dystroglycan deficiency.
|
18513969 |
2008 |
Coronary Microvascular Disease
|
0.040 |
Biomarker
|
disease |
BEFREE |
As part of a multicentric Italian study we screened the POMT1 and POMT2 genes in 61 congenital muscular dystrophy (CMD) patients with alpha-dystroglycan reduction on muscle biopsy and/or clinical and radiological findings suggestive of the known forms of CMD with alpha-dystroglycan deficiency.
|
18513969 |
2008 |
CRANIOMETAPHYSEAL DYSPLASIA, AUTOSOMAL DOMINANT
|
0.040 |
GeneticVariation
|
disease |
BEFREE |
Our data suggest the existence of a disease spectrum of CMD including brain and eye abnormalities resulting from POMT1 mutations.
|
16575835 |
2006 |
CAMPOMELIC DYSPLASIA
|
0.040 |
GeneticVariation
|
disease |
BEFREE |
Our data suggest the existence of a disease spectrum of CMD including brain and eye abnormalities resulting from POMT1 mutations.
|
16575835 |
2006 |
Coronary Microvascular Disease
|
0.040 |
GeneticVariation
|
disease |
BEFREE |
Our data suggest the existence of a disease spectrum of CMD including brain and eye abnormalities resulting from POMT1 mutations.
|
16575835 |
2006 |